Keegan M T, Flick R P, Matsumoto J Y, Davis D H, Lanier W L
Department of Anesthesiology, Mayo Clinic and Mayo Medical School, Rochester, Minnesota 55905, USA.
J Neurosurg Anesthesiol. 2000 Apr;12(2):107-11. doi: 10.1097/00008506-200004000-00006.
We report the numerous management challenges surrounding the care of a child in whom bilateral thalamotomies were used to treat end-stage Hallervorden-Spatz Disease (HSD). The management of this patient was greatly facilitated by the use of modern anesthetic agents and a multidisciplinary team to care for the patient. The outcome was an improved life expectancy and quality of life.
我们报告了围绕一名接受双侧丘脑切开术治疗终末期苍白球黑质红核色素变性(HSD)患儿护理的众多管理挑战。使用现代麻醉剂和多学科团队来护理该患者极大地促进了对该患者的管理。结果是预期寿命和生活质量得到了改善。